Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
At its meeting in May, the European Medicines Agency’s (EMA) expert committee, the CHMP, has given its positive opinion for nine drugs, and has recommended that the indication be extended for four. Only two have not made the cut, according the committee’s meeting highlights.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Four drugs recommended for approval by CHMP at April meeting
For subscribers
Danish Medicines Council rejects Novartis breast cancer drug
For subscribers
